Dogwood Therapeutics, Inc. (DWTX)
NASDAQ: DWTX · Real-Time Price · USD
4.780
+0.220 (4.82%)
At close: May 12, 2025, 4:00 PM
4.970
+0.190 (3.97%)
After-hours: May 12, 2025, 7:55 PM EDT

Dogwood Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2018 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
Selling, General & Admin
9.728.73.724.254.859.81
Upgrade
Research & Development
5.623.531.738.0710.80.19
Upgrade
Operating Expenses
15.3412.235.4512.3215.6410.01
Upgrade
Operating Income
-15.34-12.23-5.45-12.32-15.64-10.01
Upgrade
Interest Expense
-0.26-0.09----0.38
Upgrade
Interest & Investment Income
--0.150.070.01-
Upgrade
Currency Exchange Gain (Loss)
-0.05-0.03----
Upgrade
Other Non Operating Income (Expenses)
-----0.04
Upgrade
EBT Excluding Unusual Items
-15.66-12.35-5.3-12.25-15.64-10.35
Upgrade
Legal Settlements
-----0.33-
Upgrade
Pretax Income
-23.05-12.35-5.3-12.25-15.96-10.35
Upgrade
Income Tax Expense
0.19-0----
Upgrade
Net Income
-23.24-12.35-5.3-12.25-15.96-10.35
Upgrade
Preferred Dividends & Other Adjustments
0.510.51----
Upgrade
Net Income to Common
-23.75-12.86-5.3-12.25-15.96-10.35
Upgrade
Shares Outstanding (Basic)
111000
Upgrade
Shares Outstanding (Diluted)
111000
Upgrade
Shares Change (YoY)
57.24%36.84%69.62%32.91%69.06%1.96%
Upgrade
EPS (Basic)
-19.87-12.52-7.05-27.66-47.90-52.50
Upgrade
EPS (Diluted)
-19.87-12.52-7.05-27.66-48.00-52.50
Upgrade
EBITDA
--12.22----
Upgrade
D&A For EBITDA
-0.01----
Upgrade
EBIT
-15.34-12.23-5.45-12.32-15.64-10.01
Upgrade
Updated May 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q